Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kento Kumon"'
Autor:
Keisuke Taniuchi, Koji Ookawauchi, Kento Kumon, Tatsuaki Sumiyoshi, Jun Iwata, Mutsuo Furihata, Toshio Nakamura, Junko Uchiumi
Publikováno v:
Case Reports in Medicine, Vol 2015 (2015)
The size and shape of intramucosal signet ring gastric cancer in this case remained endoscopically unchanged for 15 months. Laparoscopy-assisted distal gastrectomy was performed, and immunohistochemical analysis revealed Ki-67 and p53 mutations to be
Externí odkaz:
https://doaj.org/article/2a2c3fd714be40949f86ca87dba27d8e
Publikováno v:
Asian Journal of Endoscopic Surgery.
Publikováno v:
Journal of Bioscience and Bioengineering. 130:637-643
Therapeutic monoclonal antibodies recognize and bind specific molecules on the surface of target cells, stimulating the immune system, which can attack these targeted cells. These antibodies are produced by mammalian cells, including Chinese hamster
Autor:
Nobuhiko Kanaya, Tomoko Tsumura, Ryoma Sugimoto, Toshiyoshi Fujiwara, Satoru Kikuchi, Masashi Hashimoto, Yasuo Urata, Hiroshi Tazawa, Kento Kumon, Masahiko Nishizaki, Shinji Kuroda, Yuki Hamada, Yoshihiko Kakiuchi, Chiaki Yagi, Shunsuke Kagawa
Publikováno v:
Mol Ther
Extracellular vesicles (EVs) play important roles in various intercellular communication processes. The abscopal effect is an interesting phenomenon in cancer treatment, in which immune activation is generally considered a main factor. We previously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::694e1e8c95f8e15ca5b3ea376ea13ad5
https://europepmc.org/articles/PMC8530926/
https://europepmc.org/articles/PMC8530926/
Autor:
Yasuo Urata, Satoru Kikuchi, Masashi Hashimoto, Nobuhiko Kanaya, Hiroyuki Mizuguchi, Kento Kumon, Shunsuke Kagawa, Tomoko Tsumura, Katsuyuki Aoyama, Tetsushi Kubota, Yoshihiko Kakiuchi, Masahiko Nishizaki, Shinji Kuroda, Toshiyoshi Fujiwara, Hiroshi Tazawa, Toshiaki Morihiro
Publikováno v:
Mol Ther
The clinical benefit of monotherapy involving immune checkpoint inhibitors (ICIs) such as anti-programmed death-1 antibody (PD-1 Ab) is limited to small populations. We previously developed a telomerase-specific oncolytic adenovirus, Telomelysin (OBP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f7e840e5e7e2a07a49da0c071434c45
https://europepmc.org/articles/PMC7054725/
https://europepmc.org/articles/PMC7054725/
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 78:1332-1335
Autor:
Kento Kumon, Tatsuaki Sumiyoshi, Keisuke Taniuchi, Mutsuo Furihata, Koji Ookawauchi, Junko Uchiumi, Jun Iwata, Toshio Nakamura
Publikováno v:
Case Reports in Medicine
Case Reports in Medicine, Vol 2015 (2015)
Case Reports in Medicine, Vol 2015 (2015)
The size and shape of intramucosal signet ring gastric cancer in this case remained endoscopically unchanged for 15 months. Laparoscopy-assisted distal gastrectomy was performed, and immunohistochemical analysis revealed Ki-67 and p53 mutations to be
Autor:
Masashi Uda, Takahiro Yoshioka, Kento Kumon, Hajime Nakai, Hirokazu Uetsuka, Toshihiro Murata
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 76:3018-3022
Autor:
Kento Kumon, Toshiyoshi Fujiwara, Tomoko Tsumura, Satoru Kikuchi, Shunsuke Kagawa, Hiroshi Tazawa, Nobuhiko Kanaya, Yasuo Urata, Masahiko Nishizaki, Shinji Kuroda, Yoshihiko Kakiuchi
Publikováno v:
Cancer Research. 79:4851-4851
Background: The abscopal effect is a phenomenon that shrinkage of metastatic tumors occurs concurrently with shrinkage of primary tumors by local treatments such as radiotherapy, and is generally considered to be caused through activation of the immu
Autor:
Kento Kumon, Tetsushi Kubota, Shinji Kuroda, Nobuhiko Kanaya, Yoshihiko Kakiuchi, Tomoko Tsumura, Satoru Kikuchi, Shunsuke Kagawa, Hiroshi Tazawa, Toshiyoshi Fujiwara
Publikováno v:
Cancer Research. 79:3617-3617
While trastuzumab (Tmab), a monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2), has greatly contributed to improve survival outcomes in metastatic gastric cancer, an issue of concern is that no current HER2-targeted